Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Ovarian Neoplasms 8Neuroblastoma 8Carcinoma, Ovarian Epithelial 6Uterine Cervical Neoplasms 4Fallopian Tube Neoplasms 4Sarcoma 3Leukemia 3Ganglioneuroblastoma 3Central Nervous System Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Oligodendroglioma 2Neuroectodermal Tumors, Primitive, Peripheral 2Brenner Tumor 2Brain Neoplasms 2Wilms Tumor 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrence 1Pleuropulmonary blastoma 1Optic Nerve Glioma 1Neoplasms, Unknown Primary 1Meningeal Carcinomatosis 1Medulloblastoma 1Malignant mesenchymal tumor 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma 1Lung Neoplasms 1Localized Extraskeletal Ewing Sarcoma 1Leukemia, Promyelocytic, Acute 1Leukemia, Myelomonocytic, Juvenile 1

Interventions

Radiotherapy 9Vincristine 8Dactinomycin 8Cyclophosphamide 8Ifosfamide 6Radiation 5Filgrastim 5Doxorubicin 5Irinotecan 4sargramostim 3pegfilgrastim 2brostallicin 2Vinorelbine 2Specimen Handling 2Magnetic Resonance Spectroscopy 2Granulocyte Colony-Stimulating Factor 2Biopsy 2trioctyl phosphine oxide 1perifosine 1lorvotuzumab mertansine 1irinotecan sucrosofate 1imetelstat 1exatecan 1etoposide phosphate 1X-Rays 1Trabectedin 1Topotecan 1Surgical Procedures, Operative 1Spinal Puncture 1Sentinel Lymph Node Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Rhabdomyosarcoma × Topotecan × Clear all
NCT00003958 2013-06-17

Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma

Children's Oncology Group

Phase 3 Completed
702 enrolled
Sarcoma

Malignant mesenchymal tumor, Rhabdomyosarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡